文献速递头颈部肿瘤放疗中枢神经肿瘤放疗放疗物理与技术

鼻咽癌调强放疗后颞叶损伤的NTCP预测模型:基于中国大型登记数据库的回顾性研究

Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China.
PubMed 文献 · Radiother Oncol · 2021-01-21

该研究基于8194例接受调强放疗的鼻咽癌患者,回顾性构建颞叶损伤的预测模型。D0.5cc是最具预测价值的剂量学因素,5年5%和50%颞叶损伤概率的耐受剂量分别为65.06 Gy和89.75 Gy。包含年龄、T分期和D0.5cc的列线图预测能力显著优于单一剂量学模型。

要点

  • D0.5cc是预测颞叶损伤的最强剂量学因素,AUC为0.799。
  • 5年5%和50%颞叶损伤概率的耐受剂量分别为65.06 Gy和89.75 Gy。
  • 年龄、T分期联合D0.5cc的列线图可精准预测颞叶损伤并指导个体化随访。

核心结论

  • D0.5cc是颞叶损伤的最强预测剂量学因素,其5年5%和50%概率耐受剂量分别为65.06 Gy和89.75 Gy。
  • 包含年龄、T分期和D0.5cc的列线图预测颞叶损伤的C-index在训练集为0.78、测试集为0.775,均显著优于仅含D0.5cc的模型。
  • 降低D0.5cc可减少颞叶损伤风险,尤其在年龄较大、T分期较晚的患者中。

研究设计与样本

  • 回顾性分析8194例接受调强放疗的鼻咽癌患者,颞叶损伤由磁共振成像诊断。
  • 采用惩罚回归和机器学习筛选剂量学因素,计算AUC,并构建含或不含临床变量的Cox比例风险模型。
  • 生成列线图可视化Cox回归以预测无颞叶损伤生存。

主要发现

  • 中位随访66.8个月(IQR 54.2-82.2个月)期间,12.1%(989/8194)患者发生颞叶损伤。
  • 从调强放疗到颞叶损伤的中位潜伏期为36个月(IQR 28-47个月)。
  • D0.5cc的AUC为0.799,是最具预测价值的剂量学因素。
  • 列线图定义的髙危组5年无颞叶损伤生存更差。

关键数值与推荐

  • 5年5%颞叶损伤概率的耐受剂量为65.06 Gy(95%CI 64.19-65.92)。
  • 5年50%颞叶损伤概率的耐受剂量为89.75 Gy(95%CI 87.39-92.11)。
  • 列线图C-index在训练集为0.78(仅D0.5cc模型0.737),测试集为0.775(仅D0.5cc模型0.73),两者P<0.001。

临床怎么用

  • 临床可参考D0.5cc的5年5%和50%耐受剂量(65.06 Gy和89.75 Gy)优化调强放疗计划。
  • 对年龄较大、T分期较晚的患者应更严格控制颞叶D0.5cc以降低损伤风险。
  • 列线图可用于个体化预测颞叶损伤风险并制定随访管理策略。

局限性

  • 本研究为回顾性研究,可能存在选择偏倚。
  • 研究来自中国单一大型登记数据库,外部推广性需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop predictive models with dosimetric and clinical variables for temporal lobe injury (TLI) in nasopharyngeal carcinoma (NPC) after intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS: Data of 8194 NPC patients who received IMRT-based treatment were retrospectively reviewed. TLI was diagnosed by magnetic resonance imaging. Dosimetric factors were selected by penalized regression and machine learning, with area under the receiver operating curve (AUC) calculated. Cox proportional hazards models containing the most predictive dosimetric factor with/without clinical variables were performed. A nomogram was generated as a visualization of Cox regression for predicting TLI-free survival. RESULTS: During median follow-up of 66.8 months (interquartile range [IQR] 54.2-82.2 months), 12.1% of patients (989/8194) developed TLI. Median latency from IMRT to TLI was 36 months (IQR 28-47 months). D0.5cc (dose delivered to 0.5-cm3 temporal-lobe volume) was the most predictive dosimetric factor (AUC: 0.799). Tolerance dose for 5% and 50% probabilities to develop TLI in 5 years were 65.06 Gy (95% confidence interval [CI]: 64.19-65.92) and 89.75 Gy (95% CI: 87.39-92.11), respectively. A nomogram comprising age, T stage, and D0.5cc significantly outperformed the model with only D0.5cc in predicting TLI (C-index: 0.78 vs. 0.737 in train set; 0.775 vs. 0.73 in test set; both P < 0.001). The nomogram-defined high-risk group had worse 5-year TLI-free survival. CONCLUSIONS: D0.5cc of 65.06 Gy was the tolerance dose of the temporal lobe. Reducing D0.5cc decreased risk of TLI, especially in older patients with advanced T stage. The nomogram could predict TLI precisely and allow individualized follow-up management.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wen DW, Lin L, Mao YP, et al. Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China. Radiother Oncol. 2021. PMID: 33484752. doi:10.1016/j.radonc.2021.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。